ArticleBreast cancer (Tokyo, Japan)2025

Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer.

Takuya Nishina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.